SING GEORGE L - Insider Non-Derivative Transactions at REGENERON PHARMACEUTICALS, INC. (REGN) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Sep 4, 2024, SING GEORGE L's relationship to REGENERON PHARMACEUTICALS, INC. (REGN) is Director, and currently has 26,272 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other REGN insiders.

Data Source: SEC.
SING GEORGE L - Insider Non-Derivative Transactions of REGN Common Stock
SING GEORGE L - Insider Non-Derivative Transactions at REGN
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Sep 5, 2024 G -- (Common Stock) 1200 0 26272
May 4, 2024 F -- (Common Stock) 877 942.53 27472
May 4, 2024 M -- (Common Stock) 2000 413.33 28349
Feb 27, 2024 Sell -- (Common Stock) 500 995 26349
Feb 27, 2024 Sell -- (Common Stock) 500 990 26349
Feb 27, 2024 M -- (Common Stock) 500 413.33 26849
Feb 24, 2024 Sell -- (Common Stock) 500 985 26349
Feb 24, 2024 M -- (Common Stock) 500 413.33 26849
Feb 23, 2024 Sell -- (Common Stock) 1000 960 26349
Feb 23, 2024 Sell -- (Common Stock) 1000 965 26349
Feb 23, 2024 Sell -- (Common Stock) 1000 970 26349
Feb 23, 2024 M -- (Common Stock) 1000 413.33 27349
Feb 10, 2024 Sell -- (Common Stock) 500 955 26349
Feb 10, 2024 M -- (Common Stock) 500 413.33 26849
Feb 9, 2024 Sell -- (Common Stock) 500 945 26349
Feb 9, 2024 M -- (Common Stock) 500 413.33 26849
Jan 3, 2024 Acquisition -- (Common Stock) 135 0 26349
Jan 4, 2023 Acquisition -- (Common Stock) 165 0 26214